These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21856017)

  • 21. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.
    Carmody TJ; Rush AJ; Bernstein I; Warden D; Brannan S; Burnham D; Woo A; Trivedi MH
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):601-11. PubMed ID: 16769204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Montgomery and Åsberg Depression Rating Scale - self-assessment for use in adolescents: an evaluation of psychometric and diagnostic accuracy.
    Ntini I; Vadlin S; Olofsdotter S; Ramklint M; Nilsson KW; Engström I; Sonnby K
    Nord J Psychiatry; 2020 Aug; 74(6):415-422. PubMed ID: 32125211
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assessment of DSM-IV criteria for major depression in psychiatric out- and inpatients.
    Svanborg P; Ekselius L
    Nord J Psychiatry; 2003; 57(4):291-6. PubMed ID: 12888397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) in Colombia].
    Cano JF; Gomez Restrepo C; Rondón M
    Rev Colomb Psiquiatr; 2016; 45(3):146-55. PubMed ID: 27569008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial.
    Kim HK; Lenze EJ; Ainsworth NJ; Blumberger DM; Brown PJ; Flint AJ; Karp JF; Lavretsky H; Lenard E; Miller JP; Reynolds CF; Roose SP; Mulsant BH
    J Affect Disord; 2024 Sep; 361():651-658. PubMed ID: 38925306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA).
    Takahashi N; Tomita K; Higuchi T; Inada T
    Hum Psychopharmacol; 2004 Apr; 19(3):187-92. PubMed ID: 15079853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity classification on the Hamilton Depression Rating Scale.
    Zimmerman M; Martinez JH; Young D; Chelminski I; Dalrymple K
    J Affect Disord; 2013 Sep; 150(2):384-8. PubMed ID: 23759278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation of the Psychotic Depression Assessment Scale (PDAS) against independent global severity ratings in older adults.
    Vermeulen T; Lemey L; Van Diermen L; Schrijvers D; Madani Y; Sabbe B; Van Den Bossche MJA; van der Mast RC; Østergaard SD
    Acta Neuropsychiatr; 2018 Aug; 30(4):203-208. PubMed ID: 29501075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of the Affective Self Rating Scale for manic, depressive, and mixed affective states.
    Adler M; Liberg B; Andersson S; Isacsson G; Hetta J
    Nord J Psychiatry; 2008; 62(2):130-5. PubMed ID: 18569776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining remission by cut off score on the MADRS: selecting the optimal value.
    Hawley CJ; Gale TM; Sivakumaran T;
    J Affect Disord; 2002 Nov; 72(2):177-84. PubMed ID: 12200208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
    Prisciandaro JJ; Tolliver BK
    J Affect Disord; 2016 Nov; 205():73-80. PubMed ID: 27420134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of subjective vs. objective remission status on subjective cognitive impairments in depression.
    Sawada K; Yoshida K; Ozawa C; Mizuno Y; Rubinstein EB; Suzuki T; Mimura M; Uchida H
    J Affect Disord; 2019 Mar; 246():99-104. PubMed ID: 30578953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder.
    Tomita T; Sato Y; Nakagami T; Tsuchimine S; Kaneda A; Kaneko S; Nakamura K; Yasui-Furukori N
    Clin Neuropharmacol; 2016; 39(3):135-9. PubMed ID: 27171569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence.
    Hobden B; Schwandt ML; Carey M; Lee MR; Farokhnia M; Bouhlal S; Oldmeadow C; Leggio L
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1220-1227. PubMed ID: 28421616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.
    Brecht S; Desaiah D; Marechal ES; Santini AM; Podhorna J; Guelfi JD
    J Clin Psychiatry; 2011 Aug; 72(8):1086-94. PubMed ID: 20868642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.
    Hooper CL; Bakish D
    J Psychiatry Neurosci; 2000 Mar; 25(2):178-84. PubMed ID: 10740991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response Inconsistency of Patient-Reported Symptoms as a Predictor of Discrepancy Between Patient and Clinician-Reported Depression Severity.
    Conijn JM; Emons WHM; Page BF; Sijtsma K; Van der Does W; Carlier IVE; Giltay EJ
    Assessment; 2018 Oct; 25(7):917-928. PubMed ID: 27630204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of depression in Parkinson's disease: the contribution of somatic symptoms to the clinimetric performance of the Hamilton and Montgomery-Asberg rating scales.
    Reijnders JS; Lousberg R; Leentjens AF
    J Psychosom Res; 2010 Jun; 68(6):561-5. PubMed ID: 20488273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.